Carregant...
The cell cycle checkpoint inhibitors in the treatment of leukemias
The inhibition of the DNA damage response (DDR) pathway in the treatment of cancers has recently reached an exciting stage with several cell cycle checkpoint inhibitors that are now being tested in several clinical trials in cancer patients. Although the great amount of pre-clinical and clinical dat...
Guardat en:
| Publicat a: | J Hematol Oncol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5371185/ https://ncbi.nlm.nih.gov/pubmed/28356161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-017-0443-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|